Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 58-63, March 2007

Chemical Ablation of Liver Cancer

  • Timothy W.I. Clark, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Timothy W.I. Clark, MD, Associate Professor of Radiology, Chief, Vascular and Interventional Radiology, New York University School of Medicine, Suite HE-221, 560 First Avenue, New York, NY 10016.

Department of Radiology, New York University School of Medicine, New York, NY.

Percutaneous chemical ablation is an established image-guided therapy for liver cancer that is relatively simple to perform and requires no specialized equipment. Chemical ablation has been used extensively for hepatocellular carcinoma (HCC), and has achieved outcomes comparable to surgical resection for small, solitary HCC. More recent experience with chemical ablation has combined it with TACE or thermal ablation as part of a multimodality approach to liver cancer.

Keywords: hepatocellular carcinoma, chemical ablation, ethanol ablation, acetic acid ablation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1089-2516(07)00074-1

doi:10.1053/j.tvir.2007.08.004

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 58-63, March 2007

Article Tools

* Image Usage & Resolution